Update on the EpiPen® Shortage
Tue, Jul 31, 2018
Pfizer Canada does not expect to be able to provide new supply until the end of August.
The company has also advised that, at this time, they continue to be able to supply EpiPen Jr (0.15 mg)®; however, the supply is limited and is being carefully managed at the national level.
- During the shortage, and given the likelihood that quantities are expected to deplete across all pharmacies, pharmacists are encouraged to only process one EpiPen® per patient (where possible), effective immediately, to preserve supply in order to provide care to as many patients as possible until the product becomes available.
- EpiPen® products expire on the last day of the month indicated on the product packaging. For example, if the product is marked as expiring in August/2018, it remains valid (not expired) until August 31, 2018.
- Health Canada recommends that in this shortage situation if an individual is experiencing an anaphylactic reaction and has only an expired auto-injector immediately available, they should use the expired product and immediately contact 911. Regardless of whether the product is expired, as usual, a patient should get to the nearest hospital as soon as possible following the administration of the product.
- If pharmacies or patients do not have access to any form of EpiPen®, manual injection of epinephrine is an option. PAS worked together with medSask to create a supportive document on how to create an "epinephrine kit" and how to teach patients to administer a manual injection of epinephrine. Also, medSask created a video that can be used as a support for pharmacists and patients in the teaching process. PAS highly recommends that all pharmacists become familiar with kit contents and how to administer manual epinephrine.
- Pharmacists can reference the "Anaphylaxis Protocol" document on the PAS website, under the Influenza Immunization Program (and other injectables) area for information on dosing and other anaphylaxis protocol.
- There is a bulletin developed with input from Health Canada, Pfizer and pharmacy stakeholders which includes additional information and FAQs on the shortage.
If you have any questions or require additional support in managing an Epipen® shortage, please contact email@example.com.Return to list
Update on the EpiPen® Shortage
On July 30, Health Canada issued an Information Update, indicating that the supply of EpiPen® in the 0.3 mg format is expected to be very limited at pharmacies during the month of August. This means that while some pharmacies may currently have some invenMore
2018-2019 Seasonal Influenza Immunization Program Participation
The Drug Plan and Extended Benefits Branch (DPEBB) is registering pharmacies that plan to participate in the Province’s 2018-2019 Seasonal Influenza Immunization Program (the Program).More
PAS Pharmacist Leader Opportunity
PAS has a temporary opportunity for the role of Director of Professional Practice with the Association for up to 12 months.More
Disability Tax Credit
There is a disability tax credit offered to those with ostomyMore